Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_assertion type Assertion NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_head.
- NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_assertion description "[The recombinant form of human erythropoietin is in clinical use for the prevention and treatment of anemia that is associated with cancer and its treatment with chemoradiation therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_provenance.
- NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_assertion evidence source_evidence_literature NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_provenance.
- NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_assertion SIO_000772 15467711 NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_provenance.
- NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_assertion wasDerivedFrom befree-20150227 NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_provenance.
- NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_assertion wasGeneratedBy ECO_0000203 NP378323.RAZcrgOCXb3GP-TL18paCgE1s_gPE6akYD2Gu4oaO8JLQ130_provenance.